Molmir Inc. is a Japanese biotech startup originating from Nara Medical University, AIST, and Tokushima University. The company has developed a unique technology for observing molecular dynamics through phase separation research in living cells. Molmir focuses on developing innovative diagnostics and targeted therapeutics, particularly for ALS, Parkinson's disease, and acquired von Willebrand Syndrome. It is a drug discovery platform company, not a contract manufacturer or CDMO.
Molecular dynamics detection, phase separation research, drug discovery, diagnostics development, neurodegenerative disease therapeutics
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.